Hellenic Dynamics secures long term funding for cannabis project

(Alliance News) - Hellenic Dynamics PLC on Monday said it had entered an agreement to receive ...

Alliance News 22 April, 2024 | 1:36PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Hellenic Dynamics PLC on Monday said it had entered an agreement to receive EUR1 million worth of funds.

The Greece-based cultivator and supplier of pharmaceutical standard medical cannabis products said it subsidiary, Hellenic Dynamics SA, obtained funding from an undisclosed European investor focused on health products.

Hellenic Dynamics has secured a 15-year loan agreement worth EUR1 million with an annual interest rate of 3.5%, although for the first six months, repayments will be made on an interest only basis.

The loan agreement has been guaranteed by a leading insurer through an insurance policy, with Hellenic Dynamics paying a fee equating to 2.5% of the total loan amount.

Executive Director Fillipos Papadopoulos said: "By securing the loan agreement Hellenic Dynamics SA will significantly reduce the median cost of financing for the company in its growth stage...We are also in advanced discussions on additional financing with a number of parties for expedited growth and further announcements will be released to the market in due course."

Proceeds from the loan are to be used to complete the development of company's 195,596 square metre facility in northern Greece, alongside additional working capital requirements.

Hellenic Dynamics shares were up 12% to 2.62 pence each in London on Monday afternoon.

By Elijah Dale, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Hellenic Dynamics PLC 2.25 GBX -2.17 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures